Greenleaf Trust’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,500
Closed -$315K 901
2026
Q1
$315K Sell
1,500
-93
-6% -$23.4K ﹤0.01% 637
2025
Q4
$453K Sell
1,593
-68
-4% -$21.3K ﹤0.01% 530
2025
Q3
$513K Sell
1,661
-28
-2% -$8.77K ﹤0.01% 493
2025
Q2
$531K Sell
1,689
-138
-8% -$39.8K ﹤0.01% 472
2025
Q1
$480K Buy
1,827
+17
+0.9% +$4.6K ﹤0.01% 509
2024
Q4
$473K Buy
1,810
+27
+2% +$6.8K ﹤0.01% 514
2024
Q3
$415K Buy
1,783
+72
+4% +$14.8K ﹤0.01% 561
2024
Q2
$345K Buy
+1,711
New +$308K ﹤0.01% 576
2024
Q1
Sell
-1,271
Closed -$276K 790
2023
Q4
$276K Buy
+1,271
New +$218K ﹤0.01% 619

Other funds holding PODD

Greenleaf Trust's PODD Position: Q2 2026 in Review

Greenleaf Trust sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,500 shares — an estimated $315K sold.

Greenleaf Trust first reported a position in PODD in Q4 2023 and held it in 9 quarters. The position peaked at $531K in Q2 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Greenleaf Trust reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Greenleaf Trust sold 1,500 Insulet shares in Q2 2026, an estimated $315K.
  • Greenleaf Trust first reported a position in Insulet in Q4 2023 and held it in 9 quarters.
  • Greenleaf Trust's Insulet position peaked at $531K in Q2 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.